| 10556900 |
TrkA kinase inhibitors, compositions and methods thereof |
Craig A. Stump, Yi-Heng Chen, Ping Liu, Dongfang Meng, Jane Yang Wu +1 more |
2020-02-11 |
$128,764,000 |
| 10280229 |
Linkers and their application towards ADC |
Jian Li, Yong CANG, Shuhui CHEN, Gang Li, Xiongbin XU +1 more |
2019-05-07 |
|
| 9975888 |
Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
Craig A. Coburn, Milana Maletic, Yunfu Luo, Zhiqi Qi, Tingting Yu |
2018-05-22 |
$64,896,000 |
| 9914736 |
TrKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Xu-Fang Zhang +6 more |
2018-03-13 |
$78,687,000 |
| 9896447 |
TrkA kinase inhibitors, compositions and methods thereof |
Andrew Cooke, Craig A. Stump, Xu-Fang Zhang, Qinghua Mao |
2018-02-20 |
$282,753,000 |
| 9862716 |
TRKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Yi-Heng Chen +10 more |
2018-01-09 |
$60,079,000 |
| 9862707 |
TrkA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Harold B. Wood, Qinghua Mao, Zhiqi Qi |
2018-01-09 |
$60,079,000 |
| 9815846 |
TrkA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Yi-Heng Chen +13 more |
2017-11-14 |
$82,691,000 |
| 9718782 |
TrkA kinase inhibitors, compositions and methods thereof |
Andrew Cooke, Craig A. Stump, Xu-Fang Zhang, Qinghua Mao |
2017-08-01 |
$68,609,000 |
| 9718819 |
Non-nucleoside reverse transcriptase inhibitors |
Kenneth L. Arrington, Christopher S. Burgey, Robert Gilfillan, Yongxin Han, Mehul Patel +2 more |
2017-08-01 |
$68,609,000 |
| 9469634 |
Non-nucleoside reverse transcriptase inhibitors |
Yongxin Han |
2016-10-18 |
$133,900,000 |
| 9168248 |
Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
Nicolas Lachance, Jean-Philippe Leclerc, Oscar Miguel Moradei |
2015-10-27 |
|
| 8772336 |
Cathepsin cysteine protease inhibitors |
Christopher Bayly, Cameron Black, Serge Leger, Dan McKay, Christophe Mellon +9 more |
2014-07-08 |
$92,685,000 |
| 8383643 |
Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase |
Jean-Philippe Leclerc, Oscar Miguel Moradei |
2013-02-26 |
|
| 8318748 |
Cathepsin cysteine protease inhibitors |
Christopher Bayly, Cameron Black, Serge Leger, Dan McKay, Christophe Mellon +9 more |
2012-11-27 |
$59,805,000 |
| 8063224 |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
Nicolas Lachance, Jean-Philippe Leclerc, Yeeman K. Ramtohul |
2011-11-22 |
|
| 7973037 |
Cathepsin cysteine protease inhibitors |
Christopher Bayly, Cameron Black, Serge Leger, Dan McKay, Christophe Mellon +9 more |
2011-07-05 |
|
| 7799787 |
Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
Denis Deschenes, Rejean Fortin, Renata Marcella Oballa, Yeeman K. Ramtohul |
2010-09-21 |
$79,659,000 |
| 7754745 |
Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
Yeeman K. Ramtohul |
2010-07-13 |
$47,079,000 |
| 7407959 |
Cathepsin cysteine protease inhibitors |
Jacques Yves Gauthier, Christophe Mellon |
2008-08-05 |
$118,043,000 |
| 7375134 |
Cathepsin cysteine protease inhibitors |
Christopher Bayly, Cameron Black, Serge Leger, Dan McKay, Christophe Mellon +4 more |
2008-05-20 |
$121,386,000 |
| 7163932 |
Aryldifluoromethylphosphonic acids for treatment of diabetes |
Claude Dufresne, Yves LeBlanc, Cheuk K. Lau, Patrick Roy |
2007-01-16 |
$73,856,000 |
| 6677351 |
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors |
Mario Girard, Pierre Hamel, Sebastien Laliberte, Richard Friesen, Yves Girard +1 more |
2004-01-13 |
$70,543,000 |
| 6583126 |
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) |
Yves LeBlanc, Claude Dufresne, Scheigetz John, Cheuk K. Lau, Patrick Roy +2 more |
2003-06-24 |
$142,354,000 |
| RE38103 |
5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
Daniel Guay |
2003-04-29 |
|